Molecular testing, first-line treatment patterns, and survival in metastatic Colombian non–small cell lung cancer: the RECAPC multicenter registry - Top-Institutions - MDSpire

Molecular testing, first-line treatment patterns, and survival in metastatic Colombian non–small cell lung cancer: the RECAPC multicenter registry

  • By

  • Ricardo Brugés

  • Pedro Ramos

  • Milton Lombana

  • Anderson Osma

  • Néstor Llinás

  • Javier Cuello

  • Andrés Yepes

  • Ray Manneh

  • Anabelly Coronel

  • Rebeca Granadillo

  • Carolina López

  • Álvaro Osorio

  • Daniel Santa

  • Natalia Arango

  • William Mantilla

  • Diego Gómez

  • July 17, 2026

Share

Top Institutions in Oncology

Brief introduction explaining scope and methodology.

  • #1

    Colombian Association of Hematology and Oncology
    Colombian Association of Hematology and Oncology

    Bogotá, Colombia

    Key Differentiators

    • Oncology

  • #2

    Mayo Clinic
    Mayo Clinic

    Rochester, Minnesota

    Key Differentiators

    • Oncology

  • #3

    University of California, San Diego
    University of California, San Diego

    La Jolla, California

    Key Differentiators

    • Oncology

  • #4

    Sarah Cannon Research Institute
    Sarah Cannon Research Institute

    Nashville, Tennessee

    Key Differentiators

    • Oncology

  • #5

    Institut Gustave Roussy
    Institut Gustave Roussy

    Villejuif, France

    Key Differentiators

    • Oncology

Original Source(s)

Molecular testing, first-line treatment patterns, and survival in metastatic Colombian non–small cell lung cancer: the RECAPC multicenter registry

  • by Ricardo Brugés, Pedro Ramos, Milton Lombana, Anderson Osma, Néstor Llinás, Javier Cuello, Andrés Yepes, Ray Manneh, Anabelly Coronel, Rebeca Granadillo, Carolina López, Álvaro Osorio, Daniel Santa, Natalia Arango, William Mantilla, Diego Gómez

  • July 17, 2026

Related Content

Sarcopenia in breast cancer: prognostic values and emerging therapeutic strategies

Quantitative assessment of inter-observer consistency in target volume delineation following breast-conserving surgery and mastectomy

The glucose-6-phosphatase system in cancer: from endoplasmic reticulum glucose-6-phosphate flux to stemness, immune escape, and therapeutic vulnerability